L17 Quiz || BMS204 CVS Module
30 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which of the following is NOT a main line of treatment for heart failure?

Answer hidden

Which of the following is NOT a non-pharmacological therapy for heart failure?

Answer hidden

Which of the following is NOT a type of positive inotropic drug?

Answer hidden

Which of the following is NOT a cardiac glycoside?

Answer hidden

What is the mechanism of action of cardiac glycosides?

Answer hidden

Which of the following is NOT an effect of cardiac glycosides due to their positive inotropic action?

Answer hidden

What is the main therapeutic use of cardiac glycosides in atrial fibrillation?

Answer hidden

Which of the following is NOT a therapeutic use of cardiac glycosides?

Answer hidden

Which of the following is NOT an adverse effect of cardiac glycosides?

Answer hidden

Which of the following is NOT a B1-adrenoceptor agonist?

Answer hidden

A patient with heart failure is prescribed digoxin. Which of the following electrolyte imbalances would increase the risk of digoxin toxicity?

Answer hidden

A patient with atrial fibrillation is prescribed digoxin. What is the primary mechanism by which digoxin exerts its beneficial effect in this condition?

Answer hidden

Which of the following statements BEST describes the effect of cardiac glycosides on cardiac output?

Answer hidden

A patient with heart failure is started on amrinone therapy. Which of the following adverse effects is MOST important to monitor for in this patient?

Answer hidden

Which of the following is NOT a mechanism of action of amrinone?

Answer hidden

Which of the following is a common adverse effect of both cardiac glycosides and amrinone?

Answer hidden

Which of the following is a contraindication to the use of cardiac glycosides?

Answer hidden

Which of the following is NOT a mechanism by which digitalis can cause arrhythmias?

Answer hidden

Which of the following BEST describes the role of dobutamine in the treatment of heart failure?

Answer hidden

Which of the following is NOT a reason why dobutamine is NOT suitable for long-term management of chronic heart failure?

Answer hidden

Which of the following BEST describes the effect of cardiac glycosides on heart size in heart failure?

Answer hidden

Which of the following is NOT a mechanism by which cardiac glycosides increase intracellular calcium?

Answer hidden

Which of the following BEST describes the effect of cardiac glycosides on venous pressure in heart failure?

Answer hidden

Which of the following is NOT a potential adverse effect of cardiac glycosides on the gastrointestinal system?

Answer hidden

Which of the following types of heart failure are cardiac glycosides MOST effective in treating?

Answer hidden

Which of the following is NOT a potential visual disturbance associated with cardiac glycoside toxicity?

Answer hidden

Which of the following is NOT a potential cardiac effect of cardiac glycoside toxicity?

Answer hidden

Which of the following is NOT a potential non-cardiac adverse effect of cardiac glycosides?

Answer hidden

Which of the following is NOT a potential drug interaction with cardiac glycosides?

Answer hidden

Which of the following is NOT a factor that can influence the risk of cardiac glycoside toxicity?

Answer hidden

Use Quizgecko on...
Browser
Browser